logo
  

Eurozone Nov Flash Consumer Confidence Falls Unexpectedly

Eurozone's consumer confidence declined in November, defying expectations for an increase, preliminary data from the European Commission showed Friday.

The flash consumer confidence indicator decreased to -11.6 from a -11.1 in October. Economists had forecast the index to rise to -10.7.

For the EU, the consumer confidence index slid by 0.8 points to -8.2.

"There is no breakdown available yet of Eurozone consumer confidence in November, so it is not possible to ascertain at this stage why confidence fell anew. However, evidence from both the Netherlands and Belgium suggest that consumers became significantly more worried in November about the economic situation and outlook, "
Howard Archer, Chief European and UK Economist at iHS said.

"Despite dipping to a nine-month low in November, the European Commission's consumer confidence index is still modestly above its long-term average, although the situation does vary markedly between countries, "

The final figures will be released along with the economic sentiment survey data on November 27.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT